PMGC Holdings (ELAB) Other Non Operating Income (2022 - 2026)
PMGC Holdings (ELAB) posted Other Non Operating Income of $1729.0 for Q1 2026, up 100.37% sequentially from -$467186.0 in Q4 2025.
PMGC Holdings (ELAB) Other Non Operating Income (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Other Non Operating Income for 5 years, with the latest figure at $1729.0 in Q1 2026.
- Quarterly Other Non Operating Income changed N/A year-over-year to $1729.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$511543.0 (changed N/A YoY) and the FY2025 annual result came in at $21613.0, up 469.71% from the prior year.
- Other Non Operating Income climbed to $1729.0 in Q1 2026 per ELAB's latest filing, from -$467186.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.3 million in Q4 2022 and troughed at -$467186.0 in Q4 2025.
- A 5-year average of $93559.0 and a median of -$244.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income jumped 13506.56% in 2024, then slumped 1014.68% in 2025.
- Over 5 years, Other Non Operating Income stood at $1.3 million in 2022, then tumbled by 106.94% to -$91489.0 in 2023, then surged by 54.19% to -$41912.0 in 2024, then plunged by 1014.68% to -$467186.0 in 2025, then surged by 100.37% to $1729.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $1729.0, -$467186.0, and -$4174.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,729.00 |
| Dec 31, 2025 | -467,186.00 |
| Sep 30, 2025 | -4,174.00 |
| Dec 31, 2024 | -41,912.00 |
| Sep 30, 2024 | 1,343.00 |
| Jun 30, 2024 | -244.00 |
| Mar 31, 2024 | 34,723.00 |
| Dec 31, 2023 | -91,489.00 |
| Sep 30, 2023 | 3,113.00 |
| Jun 30, 2023 | -2,374.00 |
| Mar 31, 2023 | -259.00 |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 465,000.00 |